These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Characterization of lymphoid cells in the thyroid of patients with Graves' disease. Warford A; McLachlan SM; Malcolm AJ; Young ET; Farndon JR; Rees Smith B Clin Exp Immunol; 1984 Sep; 57(3):626-32. PubMed ID: 6235996 [TBL] [Abstract][Full Text] [Related]
29. Microsomal antigen-reactive lymphocyte lines and clones derived from thyroid tissue of patients with Graves' disease. Fisfalen ME; DeGroot LJ; Quintans J; Franklin WA; Soltani K J Clin Endocrinol Metab; 1988 Apr; 66(4):776-84. PubMed ID: 3257970 [TBL] [Abstract][Full Text] [Related]
30. Patterns of cellular immune responses to thyrocyte membrane antigens and specific immunoregulatory defects in autoimmune thyroid disease. O'Brien CJ; Macchia E; Cundy TF; Concetti R; McSorley CG; MacFarlane IG; Vento S; Eddleston AL J Clin Lab Immunol; 1990 Jul; 32(3):103-8. PubMed ID: 1966945 [TBL] [Abstract][Full Text] [Related]
31. Synergy in antigen presentation by thyroid epithelial cells and monocytes from patients with Graves' disease. Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Ueki Y; Nakao H; Tezuka H; Matsunaga M; Fukuda T; Ishikawa N Clin Exp Immunol; 1988 Apr; 72(1):84-90. PubMed ID: 3260842 [TBL] [Abstract][Full Text] [Related]
32. Effect of Graves' intrathyroidal lymphocytes. Effect of Graves' disease intrathyroidal lymphocytes (ITL) on xenotransplants of human thyroid tissue in athymic nude mice. Schumm-Draeger PM; Jungheim K; Caspar G; Hermann G; Fortmeyer HP; Wenisch HJ; Usadel KH Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():60-3. PubMed ID: 8981004 [TBL] [Abstract][Full Text] [Related]
33. Peripheral blood lymphocyte transformation in response to human thyroid fractions in patients with Graves' hyperthyroidism and ophthalmopathy. Wall JR; Trewin A; Joyner DM Acta Endocrinol (Copenh); 1980 Apr; 93(4):419-23. PubMed ID: 6892974 [TBL] [Abstract][Full Text] [Related]
34. Activation of membrane-bound adenylcyclase by thyroid stimulating antibodies. Karlsson FA; Dahlberg PA; Wålinder O Acta Endocrinol (Copenh); 1981 May; 97(1):60-6. PubMed ID: 6261509 [TBL] [Abstract][Full Text] [Related]
35. Autoantibody stimulation of the human thyrotropin receptor: regulation of adenylate cyclase activity, thyroglobulin and thyroid peroxidase mRNA levels in primary cultures of Graves' thyroid tissue. Collison KS; Banga JP; Barnett PS; Huang GC; McGregor AM Clin Exp Immunol; 1991 Oct; 86(1):61-5. PubMed ID: 1914236 [TBL] [Abstract][Full Text] [Related]
36. Thyroid autoantigen-induced lymphocyte proliferation in Graves' disease and Hashimoto's thyroiditis. Weetman AP; Gunn C; Hall R; McGregor AM J Clin Lab Immunol; 1985 May; 17(1):1-6. PubMed ID: 3876444 [TBL] [Abstract][Full Text] [Related]
38. Immunoreactivity to Yersinia enterocolitica antigens in patients with autoimmune thyroid disease. Arscott P; Rosen ED; Koenig RJ; Kaplan MM; Ellis T; Thompson N; Baker JR J Clin Endocrinol Metab; 1992 Jul; 75(1):295-300. PubMed ID: 1619022 [TBL] [Abstract][Full Text] [Related]
39. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [TBL] [Abstract][Full Text] [Related]
40. Correlation between thyrotropin-displacing activity and human thyroid-stimulating activity by immunoglobulins from patients with Graves' disease and other thyroid disorders. Sugenoya A; Kidd A; Row VV; Volpé R J Clin Endocrinol Metab; 1979 Mar; 48(3):398-402. PubMed ID: 218990 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]